Potent D-peptide inhibitors of HIV-1 entry
- 23 October 2007
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (43) , 16828-16833
- https://doi.org/10.1073/pnas.0708109104
Abstract
During HIV-1 entry, the highly conserved gp41 N-trimer pocket region becomes transiently exposed and vulnerable to inhibition. Using mirror-image phage display and structure-assisted design, we have discovered protease-resistant D-amino acid peptides (D-peptides) that bind the N-trimer pocket with high affinity and potently inhibit viral entry. We also report high-resolution crystal structures of two of these D-peptides in complex with a pocket mimic that suggest sources of their high potency. A trimeric version of one of these peptides is the most potent pocket-specific entry inhibitor yet reported by three orders of magnitude (IC50= 250 pM). These results are the first demonstration that D-peptides can form specific and high-affinity interactions with natural protein targets and strengthen their promise as therapeutic agents. The D-peptides described here address limitations associated with current L-peptide entry inhibitors and are promising leads for the prevention and treatment of HIV/AIDS.Keywords
This publication has 37 references indexed in Scilit:
- Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusionProceedings of the National Academy of Sciences, 2006
- XTT Formazan Widely Used to Detect Cell Viability Inhibits HIV Type 1 Infectionin Vitroby Targeting gp41AIDS Research and Human Retroviruses, 2002
- Design of a Protein Surface Antagonist Based on α-Helix Mimicry: Inhibition of gp41 Assembly and Viral Fusion We thank the National Institutes of Health for support of this work and the Deutsche Forschungsgemeinschaft (DFG) for a research fellowship to O.K.Angewandte Chemie International Edition in English, 2002
- Design and Properties of NCCG-gp41, a Chimeric gp41 Molecule with Nanomolar HIV Fusion Inhibitory ActivityJournal of Biological Chemistry, 2001
- Design of a Peptide Inhibitor that Blocks the Cell Fusion Mediated by Glycoprotein 41 of Human Immunodeficiency Virus Type 1AIDS Research and Human Retroviruses, 2000
- Structure-Based Identification of Small Molecule Antiviral Compounds Targeted to the gp41 Core Structure of the Human Immunodeficiency Virus Type 1Journal of Medicinal Chemistry, 1999
- HIV Entry and Its InhibitionPublished by Elsevier ,1998
- Identification of d -Peptide Ligands Through Mirror-Image Phage DisplayScience, 1996
- Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.Proceedings of the National Academy of Sciences, 1994
- Total Chemical Synthesis of a D-Enzyme: The Enantiomers of HIV-1 Protease Show Reciprocal Chiral Substrate SpecificityScience, 1992